Hypertrophic cardiomyopathy

87,149views

test

00:00 / 00:00

Hypertrophic cardiomyopathy

Cardio Exam 2

Cardio Exam 2

Renin-angiotensin-aldosterone system
Arterial disease
Hypertension
Renal artery stenosis
Cushing syndrome
Pheochromocytoma
Hypertriglyceridemia
Familial hypercholesterolemia
Shock
Abetalipoproteinemia
Orthostatic hypotension
Atherosclerosis and arteriosclerosis: Pathology review
Coronary artery disease: Pathology review
Peripheral artery disease: Pathology review
Hypertension: Pathology review
Shock: Pathology review
Dyslipidemias: Pathology review
ACE inhibitors, ARBs and direct renin inhibitors
Calcium channel blockers
Thiazide and thiazide-like diuretics
Adrenergic antagonists: Beta blockers
Lipid-lowering medications: Statins
Miscellaneous lipid-lowering medications
Lipid-lowering medications: Fibrates
Anatomy of the heart
Baroreceptors
Chemoreceptors
Peripheral artery disease
Atrial flutter
Premature atrial contraction
Wolff-Parkinson-White syndrome
Atrial fibrillation
Atrioventricular nodal reentrant tachycardia (AVNRT)
Ventricular tachycardia
Premature ventricular contraction
Ventricular fibrillation
Brugada syndrome
Long QT syndrome and Torsade de pointes
Atrioventricular block
Bundle branch block
Dilated cardiomyopathy
Hypertrophic cardiomyopathy
Acyanotic congenital heart defects: Pathology review
Cyanotic congenital heart defects: Pathology review
Valvular heart disease: Pathology review
Cardiomyopathies: Pathology review
Supraventricular arrhythmias: Pathology review
Ventricular arrhythmias: Pathology review
Heart blocks: Pathology review
Class I antiarrhythmics: Sodium channel blockers
Class III antiarrhythmics: Potassium channel blockers
Class II antiarrhythmics: Beta blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Coagulation (secondary hemostasis)
Platelet plug formation (primary hemostasis)
Clot retraction and fibrinolysis
Antiplatelet medications
Anticoagulants: Direct factor inhibitors
Anticoagulants: Warfarin
Anticoagulants: Heparin
Thrombolytics
Loop diuretics
Role of Vitamin K in coagulation
Hemophilia
Bernard-Soulier syndrome
Glanzmann's thrombasthenia
Hemolytic-uremic syndrome
Thrombotic thrombocytopenic purpura
Von Willebrand disease
Heparin-induced thrombocytopenia
Disseminated intravascular coagulation
Antithrombin III deficiency
Protein C deficiency
Antiphospholipid syndrome
Factor V Leiden
Protein S deficiency
Mixed platelet and coagulation disorders: Pathology review
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Hyperlipidemia
Tricuspid valve disease
Mitral valve disease
Pulmonary valve disease
Aortic valve disease
Positive inotropic medications

Assessments

Flashcards

0 / 11 complete

USMLE® Step 1 questions

0 / 1 complete

High Yield Notes

8 pages

Flashcards

Hypertrophic cardiomyopathy

0 of 11 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 1 complete

A 15-year-old boy comes to the clinic because of progressively worsening dyspnea upon exertion and chest pain for the past 6 months. He has not had prior episodes of syncope, but he does describe moments in which he felt lightheaded and weak which improved with rest. Temperature is 37.2°C (98.9°F), pulse is 65/min, respirations are 17/min, and blood pressure is 110/80 mm Hg. Physical examination shows an athletic young man in mild distress. Cardiac examination shows a 4/6 systolic crescendo-decrescendo murmur best heard between the apex and the left sternal border on auscultation. Palpation of the precordium leads to a sustained impulse best felt at the apex. Which of the following will most likely decrease the intensity of the murmur heard on the physical examination?  

External References

First Aid

2024

2023

2022

2021

Autosomal dominant disorders

hypertrophic cardiomyopathy p. 315

β -blockers p. 245

hypertrophic cardiomyopathy p. 315

Calcium channel blockers p. 323

hypertrophic cardiomyopathy p. 315

Friedreich ataxia p. 545

hypertrophic cardiomyopathy p. 315

Hypertrophic cardiomyopathy p. 315

Pompe disease p. 85

systolic murmur in p. 295

Transcript

Watch video only

Cardiomyopathy means “heart muscle disease,” so cardiomyopathy is a broad term used to describe a variety of issues that result from disease of the myocardium, or heart muscle.

When cardiomyopathy develops as a way to compensate for some other underlying disease, like hypertension or valve diseases, it’s called secondary cardiomyopathy; when it develops all by itself, it’s called primary cardiomyopathy.

Now, hypertrophic cardiomyopathy is when the walls get thick, heavy, and hypercontractile; essentially, the muscles grow a lot larger because new sarcomeres are being added parallel to existing ones.

Usually, the left ventricle is affected, and in most cases, this muscle growth is asymmetrical, meaning that the interventricular septum grows larger relative to the free wall.

These larger muscles do two things: the walls take up more room, so less blood is able to fill the ventricle; and they become more stiff and less compliant, so they can’t stretch out as much, again, leading to less filling. When the ventricles don’t fill as much, they don’t pump out as much blood, and so stroke volume goes down. Thus, the heart can fail to pump enough blood to the body; this is called heart failure. Because this is due to a dysfunction in filling, which happens during diastole, this is a type of diastolic heart failure.

In some patients, the muscle growth of the interventricular septum essentially gets in the way of the left ventricular outflow tract during systole, or ventricular contraction. This increases blood velocity through the smaller opening, and pulls the anterior leaflet of the mitral valve toward the septum. This is called the venturi effect, which further obstructs the left ventricular outflow tract. For this reason, hypertrophic cardiomyopathy is sometimes called hypertrophic obstructive cardiomyopathy.

An obstructed left ventricular outflow tract means blood is forced through a tiny opening, which tends to cause a crescendo-decrescendo murmur. A crescendo-decrescendo murmur gets louder as blood first rushes out, and then softer; this is very similar to the murmur in aortic valve stenosis.

However, the intensity of the murmur caused by hypertrophic cardiomyopathy can change depending on how much the outflow tract is obstructed. If the person squats down or does a handgrip maneuver, systemic vascular resistance increases, which makes it harder to eject blood out and increases afterload. This means that the ventricle has more blood stretching it out, so it becomes less obstructed, and the murmur becomes less intense.

If the person stands upright or does a valsalva maneuver, however, venous return decreases. This decreases preload, meaning less blood is stretching out the ventricle before ejection, and the obstruction gets larger; thus the murmur’s intensity increases.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "Hypertrophic Cardiomyopathy" Anesthesia & Analgesia (2015)
  5. "Hypertrophic cardiomyopathy: Part 1 - Introduction, pathology and pathophysiology" Annals of Cardiac Anaesthesia (2014)
  6. "Asymptomatic Hypertrophic Cardiomyopathy" Veterinary Clinics of North America: Small Animal Practice (2017)